Yale Jen
Stock Analyst at Laidlaw & Co.
(n/a)
# 4,709
Out of 4,711 analysts
12
Total ratings
9.09%
Success rate
-54.56%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yale Jen
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $7.65 | +527.45% | 1 | Jul 29, 2024 | |
MEIP MEI Pharma | Downgrades: Hold | n/a | $2.50 | - | 1 | Jul 23, 2024 | |
AFMD Affimed | Maintains: Buy | $15 → $25 | $1.19 | +2,000.84% | 1 | Jun 13, 2024 | |
PHGE BiomX | Initiates: Buy | $25 | $0.62 | +3,932.26% | 1 | May 28, 2024 | |
INAB IN8bio | Initiates: Buy | $7.5 | $0.25 | +2,914.47% | 1 | Mar 18, 2024 | |
CING Cingulate | Downgrades: Hold | n/a | $4.10 | - | 2 | Dec 22, 2023 | |
SILO Silo Pharma | Initiates: Buy | $10 | $0.88 | +1,038.95% | 1 | Aug 28, 2023 | |
TCRT Alaunos Therapeutics | Downgrades: Hold | n/a | $1.96 | - | 1 | Aug 15, 2023 | |
NLSP NLS Pharmaceutics AG | Initiates: Buy | $240 | $1.95 | +12,207.69% | 1 | Sep 6, 2022 | |
VINC Vincerx Pharma | Initiates: Buy | $30 | $0.21 | +14,385.76% | 1 | Sep 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $45.18 | - | 1 | Dec 23, 2019 |
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $7.65
Upside: +527.45%
MEI Pharma
Jul 23, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.50
Upside: -
Affimed
Jun 13, 2024
Maintains: Buy
Price Target: $15 → $25
Current: $1.19
Upside: +2,000.84%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $25
Current: $0.62
Upside: +3,932.26%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $7.5
Current: $0.25
Upside: +2,914.47%
Cingulate
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.10
Upside: -
Silo Pharma
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.88
Upside: +1,038.95%
Alaunos Therapeutics
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.96
Upside: -
NLS Pharmaceutics AG
Sep 6, 2022
Initiates: Buy
Price Target: $240
Current: $1.95
Upside: +12,207.69%
Vincerx Pharma
Sep 13, 2021
Initiates: Buy
Price Target: $30
Current: $0.21
Upside: +14,385.76%
Dec 23, 2019
Initiates: Buy
Price Target: n/a
Current: $45.18
Upside: -